Anxiety sensitivity and opioid misuse among opioid-using adults with chronic pain

References

• Center for Disease Control and Prevention. Provisional counts of drug overdose deaths, as of 8/6/2017. 2017.
   Google Scholar
• Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths - United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1445–52. doi:10.15585/mmwr.mm655051e1.
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: A retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71:821–26. doi:10.1001/jamapsychiatry.2014.366.
   PubMed Web of Science ®Google Scholar
• Nelson LS, Juurlink DN, Perrone J. Addressing the opioid epidemic. JAMA. 2015;314:1453–54. doi:10.1001/jama.2015.12397.
   PubMed Web of Science ®Google Scholar
• Blanco C, Wall MM, Okuda M, Wang S, Iza M, Olfson M. Pain as a predictor of opioid use disorder in a nationally representative sample. Am J Psychiatry. 2016;173:1189–95. doi:10.1176/appi.ajp.2016.15091179.
   PubMed Web of Science ®Google Scholar
• Novak SP, Glasheen C, Roland CL. Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adults. Subst Abuse Rehabil. 2016;7:87–98. doi:10.2147/SAR.S102251.
   PubMed Web of Science ®Google Scholar
• Dowell D, Haegerich T, Chou R. CDC guidelines for prescribing opioids for chronic pain - United States, JAMA. 2016;1:1–49. doi:10.15585/mmwr.rr6501e1.
   Google Scholar
• Lee JD, Nunes EV, Novo P, Bachrach K, Bailey GL, Bhatt S, Farkas S, et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. Lancet. 2018;391:309–18.
   PubMed Web of Science ®Google Scholar
• Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011;68:1238–46.
   PubMed Web of Science ®Google Scholar
• Lewandowski KE, Ongur D, Keshavan MS. Development of novel behavioral interventions in an experimental therapeutics world: challenges, and directions for the future. Schizophr Res. 2018;192:6–8. doi:10.1016/j.schres.2017.06.010.
   PubMed Web of Science ®Google Scholar
• Martins SS, Fenton MC, Keyes KM, Blanco C, Zhu H, Storr CL. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the national epidemiologic study on alcohol and related conditions. Psychol Med. 2012;42:1261–72. doi:10.1017/S0033291711002145.
   PubMed Web of Science ®Google Scholar
• McHugh RK, Weiss RD, Cornelius M, Martel MO, Jamison RN, Edwards RR. Distress intolerance and prescription opioid misuse among patients with chronic pain. J Pain. 2016;17:806–14. doi:10.1016/j.jpain.2016.03.004.
   PubMed Web of Science ®Google Scholar
• Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther. 1986;24:1–8. doi:10.1016/0005-7967(86)90143-9.
   PubMed Web of Science ®Google Scholar
• Zinbarg RE, Mohlman J, Hong NN. Dimensions of anxiety sensitivity. Anxiety sensitivity: theory, research, and treatment of the fear of anxiety. 1999;83–114.
   Google Scholar
• Stewart SH, Taylor S, Baker JM. Gender differences in dimensions of anxiety sensitivity. J Anxiety Disord. 1997;11:179–200. doi:10.1016/S0887-6185(97)00005-4.
   PubMed Web of Science ®Google Scholar
• Rapee RM, Medoro L. Fear of physical sensations and trait anxiety as mediators of the response to hyperventilation in nonclinical subjects. J Abnorm Psychol. 1994;103:693–99. doi:10.1037/0021-843X.103.4.693.
   PubMed Web of Science ®Google Scholar
• Zvolensky MJ, Kotov R, Antipova AV, Schmidt NB. Cross cultural evaluation of smokers risk for panic and anxiety pathology: a test in a Russian epidemiological sample. Behav Res Ther. 2003;41:1199–215. doi:10.1016/S0005-7967(03)00031-7.
   PubMed Web of Science ®Google Scholar
• Lejuez CW, Paulson A, Daughters SB, Bornovalova MA, Zvolensky MJ. The association between heroin use and anxiety sensitivity among inner-city individuals in residential drug use treatment. Behav Res Ther. 2006;44:667–77. doi:10.1016/j.brat.2005.04.006.
   PubMed Web of Science ®Google Scholar
• Tull MT, Schulzinger D, Schmidt NB, Zvolensky MJ, Lejuez CW. Development and initial examination of a brief intervention for heightened anxiety sensitivity among heroin users. Behav Modif. 2007;31:220–42. doi:10.1177/0145445506297020.
   PubMed Web of Science ®Google Scholar
• Hearon BA, Calkins AW, Halperin DM, McHugh RK, Murray HW, Otto MW. Anxiety sensitivity and illicit sedative use among opiate-dependent women and men. Am J Drug Alcohol Abuse. 2011;37:43–47. doi:10.3109/00952990.2010.535581.
   PubMed Web of Science ®Google Scholar
• McHugh RK, Votaw VR, Bogunovic O, Karakula SL, Griffin ML, Weiss RD. Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder. Addict Behav. 2017;65:283–88. doi:10.1016/j.addbeh.2016.08.020.
   PubMed Web of Science ®Google Scholar
• Lejuez CW, Zvolensky MJ, Daughters SB, Bornovalova MA, Paulson A, Tull MT, Ettinger K, Otto MW. Anxiety sensitivity: A unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment. Behav Res Ther. 2008;46:811–18.
   PubMed Web of Science ®Google Scholar
• Parsells Kelly J, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the US adult population. Pain. 2008;138:507–13. doi:10.1016/j.pain.2008.01.027.
   PubMed Web of Science ®Google Scholar
• Volkow ND, McLellan AT. Opioid abuse in chronic pain — misconceptions and mitigation strategies. N Engl J Med. 2016;374:1253–63. doi:10.1056/NEJMra1507771.
   PubMed Web of Science ®Google Scholar
• Asmundson GJG, Taylor S. Role of anxiety sensitivity in pain-related fear and avoidance. J Behav Med. 1996;19:577–86. doi:10.1007/BF01904905.
   PubMed Web of Science ®Google Scholar
• Norton PJ, Asmundson GJG. Anxiety sensitivity, fear, and avoidance behavior in headache pain. Pain. 2004;111:218–23. doi:10.1016/j.pain.2004.06.018.
   PubMed Web of Science ®Google Scholar
• Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000;85:317–32. doi:10.1016/S0304-3959(99)00242-0.
   PubMed Web of Science ®Google Scholar
• Lethem J, Slade PD, Troup JD, Bentley G. Outline of a fear-avoidance model of exaggerated pain perception–I. Behav Res Ther. 1983;21:401–08. doi:10.1016/0005-7967(83)90009-8.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JBW. The patient health questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284–92. doi:10.1097/01.MLR.0000093487.78664.3C.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146:317–25. doi:10.7326/0003-4819-146-5-200703060-00004.
   PubMed Web of Science ®Google Scholar
• Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58:163–71. doi:10.1016/j.jpsychores.2004.09.006.
   PubMed Web of Science ®Google Scholar
• Löwe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Brähler E. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122:86–95.
   PubMed Web of Science ®Google Scholar
• Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50:133–49. doi:10.1016/0304-3959(92)90154-4.
   PubMed Web of Science ®Google Scholar
• Taylor S, Zvolensky MJ, Cox BJ, Deacon B, Heimberg RG, Ledley DR, Abramowitz, JS, et al. Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3. Psychol Assess. 2007;19:176–88.
   PubMed Web of Science ®Google Scholar
• Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, Jamison RN. Development and validation of the current opioid misuse measure. Pain. 2007;130:144–56.
   PubMed Web of Science ®Google Scholar
• Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain. 2007;23:307–15. doi:10.1097/AJP.0b013e3180330dc5.
   PubMed Web of Science ®Google Scholar
• Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90:607–14.
   PubMed Web of Science ®Google Scholar
• Iraurgi Castillo I, González Saiz F, Lozano Rojas O, Landabaso Vázquez MA, Jiménez Lerma JM. Estimation of cutoff for the Severity of Dependence Scale (SDS) for opiate dependence by ROC analysis. Actas Esp Psiquiatr. 2010;38:270–77.
   PubMed Web of Science ®Google Scholar
• Smith M, Rosenblum A, Parrino M, Fong C, Colucci S. Validity of self-reported misuse of prescription opioid analgesics. Subst Use Misuse. 2010;45:1509–24. doi:10.3109/10826081003682107.
   PubMed Web of Science ®Google Scholar
• Hilbe JM. Negative Binomial Regression. Cambridge University Press; 2011.
   Google Scholar
• Ferguson CJ. An effect size primer : A Guide for clinicians and researchers. Prof Psychol Res Pract. 2009;40:532–38. doi:10.1037/a0015808.
   Web of Science ®Google Scholar
• Martel MO, Finan PH, McHugh RK, Issa M, Edwards RR, Jamison RN, Wasan AD. Day-to-day pain symptoms are only weakly associated with opioid craving among patients with chronic pain prescribed opioid therapy. Drug Alcohol Depend. 2016;162:130–36.
   PubMed Web of Science ®Google Scholar
• Leventhal AM, Zvolensky MJ. Anxiety, depression, and cigarette smoking: A transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychol Bull. 2015;141:176–212. doi:10.1037/bul0000003.
   PubMed Web of Science ®Google Scholar
• Martel MO, Jamison RN, Wasan AD, Edwards RR. The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: A preliminary analysis. Pain Med. 2014;15:1757–64. doi:10.1111/pme.12416.
   PubMed Web of Science ®Google Scholar
• Martel MO, Wasan AD, Jamison RN, Edwards RR. Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain. Drug Alcohol Depend. 2013;132:335–41. doi:10.1016/j.drugalcdep.2013.02.034.
   PubMed Web of Science ®Google Scholar
• Garland EL, Manusov EG, Froeliger B, Kelly A, Williams JM, Howard MO. Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial. J Consult Clin Psychol. 2014;82:448–59. doi:10.1037/a0035798.
   PubMed Web of Science ®Google Scholar
• Asmundson GJG, Katz J. Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art. Depress Anxiety. 2009;26:888–901. doi:10.1002/da.20600.
   PubMed Web of Science ®Google Scholar
• Keough ME, Schmidt NB. Refinement of a brief anxiety sensitivity reduction intervention. J Consult Clin Psychol. 2012;80:766–72. doi:10.1037/a0027961.
   PubMed Web of Science ®Google Scholar
• Schmidt NB, Eggleston AM, Woolaway-Bickel K, Fitzpatrick KK, Vasey MW, Richey JA. Anxiety Sensitivity Amelioration Training (ASAT): A longitudinal primary prevention program targeting cognitive vulnerability. J Anxiety Disord. 2007;21:302–19. doi:10.1016/j.janxdis.2006.06.002.
   PubMed Web of Science ®Google Scholar
• Schmidt NB, Capron DW, Raines AM, Allan NP. Randomized clinical trial evaluating the efficacy of a brief intervention targeting anxiety sensitivity cognitive concerns. J Consult Clin Psychol. 2014;82:1023–33. doi:10.1037/a0036651.
   PubMed Web of Science ®Google Scholar
• Jamison RN, Sheehan KA, Scanlan E, Matthews M, Ross EL. Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers. J Opioid Manag. 2014;10:375–82. doi:10.5055/jom.2014.0234.
   PubMedGoogle Scholar